Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹42.15
Market cap: ₹72.28 Cr
Revenue (annual): ₹171.2 Cr
Net profit (annual): ₹3.94 Cr
P/E (TTM): 18.3×Sector 47.4×
Promoter holding: 69.98%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All New Order Win 5 Annual General Meeting 4 Capital Structure Change 3 Other Announcement 2 Financial Results 2 Capacity Expansion 2 Results Correction 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Jun 2026 15:04 IST NSE

Results Correction

Zenith Drugs Results Correction

Zenith Drugs re-submitted its FY26 financial results to correct a Rs. 1.60 Crore tax provision misclassification. The correction is administrative and does not impact reported profits.

Value: ₹1.60 Cr

Read the filing ↗